Share

April 10, 2018; 90 (15 Supplement) April 27, 2018

EVOLVE-MS-1: A Phase 3, Open-Label, Long-Term Safety Study of ALKS 8700 in Relapsing-Remitting Multiple Sclerosis (P6.360)

Robert Naismith, Richard Leigh-Pemberton, David Rezendes, Narinder Nangia, Boris Kandinov, Lisa von Moltke, Jerry Wolinsky
First published April 9, 2018,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 90 no. 15 Supplement P6.360
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 9, 2018.
Copyright & Usage: 
© 2018

Author Disclosures

    1. Robert Naismith1,
    2. Richard Leigh-Pemberton2,
    3. David Rezendes2,
    4. Narinder Nangia2,
    5. Boris Kandinov2,
    6. Lisa von Moltke2 and
    7. Jerry Wolinsky3
  1. Robert Naismith1,
  2. Richard Leigh-Pemberton2,
  3. David Rezendes2,
  4. Narinder Nangia2,
  5. Boris Kandinov2,
  6. Lisa von Moltke2 and
  7. Jerry Wolinsky3
  1. 1Washington University School of Medicine St Louis MO United States
  2. 2Alkermes Waltham MA United States
  3. 3McGovern Medical School, The University of Texas Health Science Center at Houston Houston TX United States

Article usage

Article usage: April 2018 to April 2023

AbstractFullPdfSource
Apr 20183600Highwire
May 20182400Highwire
Jun 20183200Highwire
Jul 20182600Highwire
Aug 20182300Highwire
Sep 20182600Highwire
Oct 20182500Highwire
Nov 20183800Highwire
Dec 20184200Highwire
Jan 20194400Highwire
Feb 201915700Highwire
Mar 201910900Highwire
Apr 20195900Highwire
May 20198600Highwire
Jun 20197200Highwire
Jul 20199700Highwire
Aug 20198700Highwire
Sep 20195900Highwire
Oct 201914800Highwire
Nov 201919400Highwire
Dec 20195700Highwire
Jan 20208000Highwire
Feb 20204800Highwire
Mar 20203200Highwire
Apr 20203300Highwire
May 20205200Highwire
Jun 20204600Highwire
Jul 20202600Highwire
Aug 20203500Highwire
Sep 20203300Highwire
Oct 20202200Highwire
Nov 20201900Highwire
Dec 20203900Highwire
Jan 20212700Highwire
Feb 20211900Highwire
Mar 20213100Highwire
Apr 20214400Highwire
May 20212200Highwire
Jun 20211900Highwire
Jul 20213000Highwire
Aug 20212900Highwire
Sep 20212300Highwire
Oct 20212600Highwire
Nov 20212700Highwire
Dec 20212200Highwire
Jan 20222200Highwire
Feb 20221800Highwire
Mar 20222100Highwire
Apr 20222500Highwire
May 20221800Highwire
Jun 20221900Highwire
Jul 20221500Highwire
Aug 20222400Highwire
Sep 20225000Highwire
Oct 202211000Highwire
Nov 20229600Highwire
Dec 20226400Highwire
Jan 20236600Highwire
Feb 20235700Highwire
Mar 20236300Highwire
Apr 20236800Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me